State Street Corp Taro Pharmaceutical Industries LTD Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.97 - $43.33 $374,260 - $395,819	9,135 Added 5.58%	172,828 $7.32 Million
Q4 2023 Feb 14, 2024	BUY	$32.77 - $42.31 $117,414 - $151,596	3,583 Added 2.24%	163,693 $6.84 Million
Q3 2023 Nov 14, 2023	BUY	$35.46 - $40.13 $20,708 - $23,435	584 Added 0.37%	160,110 $6.04 Million
Q2 2023 Aug 14, 2023	BUY	$24.24 - $40.97 $2.46 Million - $4.16 Million	101,633 Added 175.55%	159,526 $6.05 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $31.59 $23,000 - $31,590	1,000 Added 1.76%	57,893 $1.41 Million
Q4 2022 Feb 14, 2023	SELL	$27.6 - $32.99 $41,096 - $49,122	-1,489 Reduced 2.55%	56,893 $1.65 Million
Q3 2022 Nov 15, 2022	BUY	$28.74 - $39.9 $206,928 - $287,280	7,200 Added 14.07%	58,382 $1.75 Million
Q2 2022 Aug 15, 2022	BUY	$35.0 - $43.59 $24,500 - $30,513	700 Added 1.39%	51,182 $1.85 Million
Q1 2022 May 16, 2022	SELL	$43.12 - $50.3 $73,821 - $86,113	-1,712 Reduced 3.28%	50,482 $2.18 Million
Q4 2021 Feb 14, 2022	BUY	$47.6 - $65.0 $46,362 - $63,310	974 Added 1.9%	52,194 $2.62 Million
Q3 2021 Nov 15, 2021	BUY	$62.34 - $73.38 $87,276 - $102,732	1,400 Added 2.81%	51,220 $3.26 Million
Q2 2021 Aug 16, 2021	BUY	$70.26 - $76.64 $31,476 - $34,334	448 Added 0.91%	49,820 $3.59 Million
Q1 2021 May 17, 2021	BUY	$70.48 - $79.95 $817,568 - $927,420	11,600 Added 30.71%	49,372 $3.64 Million
Q4 2020 Feb 16, 2021	BUY	$54.4 - $73.42 $1.66 Million - $2.24 Million	30,544 Added 422.58%	37,772 $2.77 Million
Q3 2020 Nov 10, 2020	BUY	$54.41 - $68.2 $49,458 - $61,993	909 Added 14.39%	7,228 $396,000
Q2 2020 Aug 14, 2020	BUY	$61.66 - $70.16 $3,021 - $3,437	49 Added 0.78%	6,319 $420,000
Q1 2020 May 11, 2020	BUY	$59.35 - $88.73 $372,124 - $556,337	6,270 New	6,270 $384,000

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account